Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.9 |
mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.0083 | 0.9 |